SiL Vascular

Company Overview

Snapshot

Founded in October 2012 by Eyal Teichman, SiL Vascular operates with 1–10 employees. The company reached a significant milestone with its closing event in November 2018.

Business overview

SiL Vascular is a medical device company developing an angioplasty double-balloon technology to enhance the treatment of peripheral vascular disease. Its system utilizes a short balloon within a long balloon, allowing physicians to inflate the long balloon to nominal pressure and then use the short balloon to target and open difficult blockages. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics for healthcare providers.

Company Intelligence Q&A

When was SiL Vascular founded?

SiL Vascular was founded in October 2012.

Who is a co-founder of SiL Vascular?

Eyal Teichman is a co-founder and CTO of SiL Vascular.

What is SiL Vascular's primary focus?

SiL Vascular is a medical device company focused on developing an angioplasty double-balloon technology for peripheral vascular disease treatment.

What is the core technology developed by SiL Vascular?

SiL Vascular's system utilizes a dual-balloon technology, featuring a short balloon moving within a long balloon, designed to target and open difficult-to-treat blockages in peripheral vascular disease.

What was a key event for SiL Vascular in November 2018?

SiL Vascular had a closing event in November 2018, marking a significant point in the company's timeline.